METTL13 and prostate carcinoma: The GEO profile database indicates that METTL13 expression is higher in normal tissues than in carcinomas, such as pancreatic cancer, prostate cancer and SP-C/c-raf transgenic tumors of lung adenocarcinomas (GEO profiles ID: 69616015, 111587413, 19101994, 69269775 and 69255944).